A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes.
Jun 30, 2011
0
0
Drugs known as thiazolidinediones, or TZDs for short, are widely used in diabetes treatment, but they come with a downside. The drugs have effects on the kidneys that lead to fluid retention as the volume of plasma in the ...
May 3, 2011
0
0
Millions of people around the world live with diabetes mellitus. Many of them have medication and specific dietary management approaches to help them maintain stable blood sugar levels. However, recent innovations, such as ...
19 hours ago
0
28
Initially, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have subsequently been marketed and widely used for weight loss. Now these medications are showing promise as a possible treatment for multiple ...
Apr 15, 2024
0
0
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
Apr 9, 2024
0
2
After a stroke, African American veterans previously diagnosed with post-traumatic stress disorder (PTSD) were significantly more likely to be re-hospitalized than those without PTSD. PTSD did not raise the risk of post-stroke ...
Mar 14, 2024
0
1
From lots of recent reports—both breathless and scientific— fasting has become a tantalizing path to health. Non-religious fasting can range from 24 hours or more without food to intermittent periods of up to 16 hours ...
Mar 7, 2024
0
2
The U.S. Food and Drug Administration on Tuesday approved the country's first over-the-counter continuous glucose monitor for type 2 diabetes.
Mar 6, 2024
0
3
Canada on Thursday unveiled a framework for a universal drug plan that, once fully implemented, would mark the biggest expansion of its publicly funded health care system in decades.
Mar 1, 2024
0
0
Diabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University ...
Feb 22, 2024
0
9
